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A B S T R A C T
Central venous catheters provide an easy access for intravenous medications. Having a central line in place will re-
lieve a child from the discomfort and danger of multiple regular intravenous lines for chemotherapy. The use of indwell-
ing central venous catheters has become commonplace in the management of children undergoing oncological treatment.
There are two types of central lines commonly used. There are Broviac catheters and Port-A-Cath (PAC) catheters. In the
last 5 years we inserted 194 catheters in 175 children. We inserted 121 Broviac catheters and 73 PAC catheters. During
the follow up of 39382 catheter days 44 complications were observed. In Broviac group the median follow up was 155
days and in PAC group was 230 days. We observed differences in the incidence between two devices. In Broviac group in-
fections were more frequent and in PAC group other complications were more frequent than infections.
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Introduction
A central venous access is always necessary for the
management of patients undergoing high dose chemo-
therapy. In our hospital we used two types of central ve-
nous catheters. There were Broviac catheters and Port-
-A-Cath (PAC) catheters.
Broviac catheter is the most common devices in cur-
rent use. They are usually manufactured from materials
such as soft silicon rubber or polyvinyl chloride (PVC).
They are available in a wide range of sizes for pediatric
use. Broviac catheters are characterized by a variable-
-sized Dacron cuff which provides an anchorage in a sub-
cutaneous tissue and may be as a microbial barrier1.
PAC catheters are totally implantable devices. The
intravascular part is made of similar material like Bro-
viac catheters.The thick injection membrane of the sys-
tem is housed in a titanium or plastic case. This provides
a more acceptable cosmetic option and allows the patient
to swim or bathe which are restricted practices with ex-
ternally exiting catheters2,3.
The lifetime of catheters is dependent on operative
technique, sterility, catheter care, thrombosis, infections,
and mechanical wear with repeated use. If we assume op-
timal asepsis at insertion and we carefully handle with
care Broviac catheters are in use more than 18 months.
PAC catheters allow 1000–2000 punctures through the
thick injection membrane4.
Broviac catheters are approximately ten times che-
aper than PAC catheters but PAC catheters have many
advantages.
Insertion Technique
In our operating procedures we use two different
techniques. The first technique is a percutaneous proce-
dure which is done utilising the Seldinger technique5.
The second technique is open cut-down procedure. There
are a number of different sites available for central ve-
nous catheters access. We prefer the subclavian site for
catheter implantation because of the perceived clean
lines and ease of tunnelling from the anterior chest wall.
The better choice for implantation is the right subclavian
vein because it has a shorter and more a direct route to
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the superior vena cava than the left. We always prefer
the tunnelled type of catheters6.
When we choose appropriate site, the full aseptic con-
ditions are necessary. In general anaesthesia a flexible
J-tip guidewire is passed centrally with X-ray verifica-
tion. The catheters or port assembly is then tunnelled or
surgically placed on the anterior chest wall. The catheter
is cut to an appropriate length. This can be done by visu-
alisation of the catheter on the anterior chest wall. A
splitting sheath is passed over an introducing dilator into
a central vein. The catheter is then passed through the
splitting sheath which is withdrawn and peeled apart.
The correct position of the intravascular part of catheter
tip is adjusted under X-ray control7,8. The optimum posi-
tion of the catheter tip is in the lower superior vena cava
or upper right atrium9.
In the operative procedure we identify the cephalic
vein and with visual control the catheter it is inserted di-
rectly into the vein after venotomy. The other procedure
is similar to the previously described percutaneous tech-
nique. Sometimes, it is difficult to put catheter in the
lower part of vena cava because catheter migrate into the
neck. In that situation it helps to pull down arm on the
ipselateral side where catheter has been inserted while
turning head towards the other side10.
Complications
In our experience we observe both early and late com-
plications. Early complications are pneumothorax11,
atrial fibrillation, aberrant catheter position in the neck
and skin necrosis above catheter. Late complications are
exit site infections, tunnel or port pocket infections, cath-
eter sepsis, catheter thrombosis, deep vein thrombosis,
catheter displacement or physical damage to the cathe-
ter12,13.
Thrombosis was defined as an intravascular clot re-
lated to the catheter that either interfered with catheter
function or produced signs or symptoms of vascular oc-
clusion. Thrombosis was detected with ultrasound and/
or venography when clinically suggested by progressive
arm or facial swelling. Infection was defined by positive
blood culture results in the setting of systemic symptoms
consistent with infection that was not attributable to an-
other source14,15.
Port pocket infection and tunnel infection was de-
fined as induration, erythema and tenderness around the
port or subcutaneous catheter tunnel with culture posi-
tive material aspired from the port pocket or tunnel16,17.
Results
In the last 5 years two different devices were inserted.
We inserted 121 Broviac catheters and 73 PAC catheters.
During the follow up of 39382 catheter days 44 complica-
tions were observed. In Broviac group the median follow
up was 155 days and in PAC group was 230 days. In
Broviac group 30 complications were observed and 14
complications were observed in PAC group. The age of
the patients at the time of surgery varied from 3 months
to 20 years. The mean age of patients with inserted cath-
eters was 5 years old.
Early complications
A pneumothorax was observed as a complication in
three patients (3/194; 1.54%). Only one patient required
a tube thoracostomy to treat a large pneumothorax. One
patient had a port and two had Broviac catheters.
Two patients with Broviac catheters (2/194; 1.03%)
experienced atrial fibrillation as a consequence of central
venous catheter. It was successfully treated with catheter
removal and re-implantation on the opposite side.
The correct position of the intravascular part of cath-
eter tip is adjusted under X-ray control. Sometimes, it is
difficult to place the catheter in the lower superior vena
cava because catheter goes up the neck veins. In this sit-
uation the previously mention manoeuvres are usually
successful to reposition the catheter tip. In our experi-
ence we had no catheters with tip position in the neck af-
ter operative procedure. In one patient (1/194; 0.52%)
with PAC skin necrosis developed ten days after implan-
tation and required catheter removal.
One patient had an accidental arterial puncture dur-
ing the implant procedure which did not cause any signif-
icant complication.
Late complications
The most common complications of central venous
catheters were infections. These infections can be di-
vided into three main groups which may coexist: exit site
infection, tunnel or pocket infection and catheter sepsis
or catheter-related bacteraemia.
Exit site infections were localised to the point at
which a device exits through the skin. We had 7 patients
(7/194; 3.6%) with Broviac catheters which had exit site
infections. Five (5/194; 2.57%) of them had infections due
Staphylococcus epidermidis and local wound care with
antibiotics and without catheter removal can be man-
aged. Two patients (2/194; 1.03%) had evidence of bacte-
remia and more virulent pathogen such Staphylococcus
aureus, such treatment may not be adequate. Antibiotics
were initially administered. When bacteremia persisted
removal of catheter was eventually required in one pa-
tient.
We had five patients (5/194; 2.57%) with tunnel or
pocket infections, two patients (2/194; 1.03%) with Bro-
viac and three (3/194; 1.54%) with port catheters. This
represents a process of suppuration or induration related
to subcutaneous tunnel (or pocket in the case of port).
Because of the presence of suppuration and foreign body,
these infections required the catheter removal and anti-
biotics.
The most serious type of infections was sepsis. We had
eight patients (8/194; 4.12%) with these type of infec-
tions including Enterobacter, Acinetobacter, Staphylo-
coccus, Candida and Enterococcus bacteremia. When
sepsis was defined antibiotics were administrated. Cath-
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eter was removed only when antibiotics treatment were
deemed inadequate. Five patients (5/194; 2.57%) with
Broviac and three patients (3/194; 1.54%) with PAC had
sepsis18,19. In four patients catheter were removed be-
cause antibiotic treatment was insufficient.
Thrombosis was defined as an intravascular clot re-
lated to the catheter that either interfered with catheter
function or produced signs or symptoms of vascular oc-
clusion. In our experience we observed only subclavian
and axillary thrombosis with swelling of the arm. We had
one patient (1/194; 0.52%) with PAC and two (2/194;
1.03%) with Broviac catheter that had deep vein throm-
bosis. Deep vein thrombosis occurred after infections and
with catheters which were in place 10 months and more.
Another aspect of catheter thrombosis is intraluminal
thrombosis which leads to obstruction to infusions or
blood administration and withdrawal of blood for analy-
sis. This complication can usually be prevented by a hep-
arin injection. Catheters are flushed with heparinized sa-
line after each use. Various solutions and strategies have
been used to aid unblocking of catheters. These include
heparin, urokinase and streptokinase. Aspiration of the
air from the lumen to create vacuum followed by connec-
tion to a syringe containing the fibrinolytic agent20,21. We
had two patients (2/124; 1.03%) with PAC and three pa-
tients (3/194; 1.54%) with intraluminal Broviac catheter
thrombosis. Catheters must be removed only when anti-
coagulation or thrombolysis are inadequate. We only re-
moved 2 catheters due to this complication.
In two (2/194; 1.03 %) PAC catheters we had extra-
vasation of drugs because catheters broken in the proxi-
mal portion. This complication was seen in four (4/194;
2.06%) Broviac catheters. Catheters were removed only
in one patient where we noticed skin necrosis.
In four patients (4/194; 2.06%) with Broviac we had
accidentally pulled out the catheter or cut catheter with
scissors and only treatment was removal of the catheters
(Table 1).
Discussion
In this observational study of 194 implanted CVC, for
a total of 39382 catheter days we described insertion
technique and complications in a 5 year period. Infec-
tions represent more frequently reported complication.
We had 20 patients (20/194; 10.31%) with all kinds of in-
fectious complications. Ten patients did not require cath-
eter removal because of successful antibiotic treatment.
The other 10 patients with infections required the cathe-
ter removal because antibiotics treatment were deemed
inadequate22.
The second complication in our study was thrombo-
sis. We had 8 patients (8/194; 4.12%) with thrombotic
events. All patients received thrombolytic drugs through
the catheters, depending on the patient’s coagulation
profile. In all 3 patients (3/194; 1.54%) with deep vein
thrombosis catheters were removed, and in patients with
intraluminal catheter thrombosis two patients required
catheter removal.
The third complication in our study was mechanical
complications such as catheter dislodgement and damage
to the catheter. We had 10 patients (10/194; 5.15%) with
mechanical complications. The best prevention of this
type of complications are education of hospital staff and
parents on how to handle and care for catheters.
Conclusion
PAC catheters provided a more acceptable cosmetic
option and allows the patient to swim or bathe which are
restricted practices with externally exiting catheters.
Broviac catheters are approximately ten times cheaper
than PAC catheters. In our hospital we try to insert PAC
to patients with long-term chemotherapy when it is pos-
sible because port catheters have more advantages than
Broviac (low percentage of complications, better cos-
metic effects, easy every day life and requires no care by
patients)23.
To avoid early complications it is necessary to im-
prove surgical technique and have an excellent team. To
avoid late complications and the best prevention of these
complications it is necessary to educate of hospital staffs
and parents how to handle and care of catheters.
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TABLE 1
EARLY AND LATE COMPLICATIONS
Complications Broviac Port-A-Cath (PAC)
Pneumothorax 1 2
Atrial fibrillation 2 0
Necrosis cutis 0 1
Exit site infections 7 0
Tunnel /port infections 2 3
Sepsis 5 3
Deep vein thrombosis 2 1
Catheter thrombosis 3 2
Drug extravasation 4 2
Catheter pull out or cut 4 0
Total 30 14
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CENTRALNI VENSKI KATETERI U TERAPIJI SOLIDNIH TUMORA
– NA[I REZULTATI UNAZAD 5 GODINA
S A @ E T A K
Centralni venski kateteri omogu}uju lak{i pristup parenteralnom lije~enju onkolo{kih bolesnika. Postavljenim cen-
tralnim venskim kateterom osloba|amo dijete psihi~kih trauma i boli tijekom lije~enja. Ugradnja centralnih venskih
katetera su postala uobi~ajeni postupak pri lije~enju onkolo{kih bolesnika. Naj~e{}e se upotrebljavaju dvije vrste kate-
tera i to Broviac kateteri i Port-A-Cath (PAC) kateteri. Unazad 5 godina ugradili smo 194 katetera kod 175 djece.
Ugradili smo 121 Broviac kateter i 73 PAC katetera. Tijekom pra}enja kroz 39382 dana koliko su ukupno kateteri bili
ugra|eni zamijetili smo 44 komplikacije. Prosje~na du`ina trajanja Broviac katetera je bila 155 dana, a PAC katetera
230 dana. U tijeku ove studije smo promatrali razlike izme|u dvije vrste katetera. U grupi Broviac katetera naju~esta-
lije su bile infekcije dok su u grupi Port katetera u~estalije bile druge komplikacije.
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